Please login to the form below

Not currently logged in
Email:
Password:

InterComm International under new management

Malcolm Allison and Ben Greeves take over the med comms agency

InterComm InternationalMedical communications agency InterComm International has changed ownership, with Malcolm Allison and Ben Greeves acquiring the firm.

Based in Cambridge, UK, InterComm had been under the leadership of chief executive Martin Lancaster and managing director David Mercer since 1998.

Allison and Greeves took over the reins in September as director and general manager respectively, working to deliver multichannel campaigns in the pharmaceutical and healthcare arena.

Outlining the agency's focus, Greeves told PMLiVE: “We want to be known for delivering excellence with integrity.

“We have a great team with experience across many different clients, covering assets including medical devices, pharmaceuticals, animal health and consumer brands.”

Greeves first joined InterComm six years ago after establishing his own digital solutions firm, while Allison brings over 30 years of pharmaceutical marketing experience to the agency.

With strategic and tactical marketing and sales experience accrued while at Actelion, Bayer, GlaxoSmithKline, Novartis and Pfizer, Allison described his agency-side move as “a natural progression”.

He told PMLiVE: “We want to help clients tell their story. As InterComm moves forward under new management, we will continue working in this fast-paced industry, delivering materials that excite, educate and inform.”

Article by
Rebecca Clifford

8th December 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health offers a unique breadth and depth of experience, across everything from early stage product commercialisation, strategy and research,...

Latest intelligence

Running
Biosimilars: what the future looks like
Biosimilars: what the future looks like...
compliance
Tightening medical device safety
European legislators seek to reduce patient exposure to safety risks...
Research Partnership has published a new Living with Ulcerative Colitis (UC) US market report for 2017
...

Infographics